This study is in progress, not accepting new patients
ATG-GCSF in New Onset Type 1 Diabetes
Diabetes Mellitus, Type 1Type 1 Diabetes TrialNetDiabetes MellitusSargramostimThymoglobulinLenograstimAntilymphocyte SerumAnti-Thymocyte Globulin (ATG)Granulocyte colony stimulating factor (GCSF)ATG plus Granulocyte colony stimulating factor (GCSF)
Lead Scientist at UCSF
- Stephen Gitelman
I am involved in a variety of different translational and clinical research projects, most related to diabetes. A number of the on-going studies are attempts to alter the course of autoimmune-mediated type 1 diabetes, often via immunomodulation, in order to preserve endogenous beta cell function. Some of the recent and on-going projects are described below.